FDA Adverse Event Injury Summary report: N

SOFTFORM FACIAL IMPLANT

MDR report key: 141690 · Received December 30, 1997

Report

Report Number
2939859-1997-00303
Event Type
Injury
Date Received
December 30, 1997
Date of Event
January 1, 1997
Report Date
December 16, 1997
Manufacturer
TISSUE TECHNOLOGIES, INC
Product Code
FTL
Adverse Event
Yes
Report Source
Distributor report
Reporter Location
FL, US
Reporter Occupation
PHYSICIAN

Narratives

Description of Event or Problem · 1

A PHYSICIAN REPORTED A PT WHO WAS IMPLANTED ON 10/17/1997 IN THE RIGHT AND LEFT NASOLABIAL FOLDS. THE PROCEDURES WERE UNEVENTFUL AND THE PT WAS DIRECTED TO APPLY COLD COMPRESSES TO BOTH SITES AND SLEEP WITH HIS HEAD ELEVATED FOR THREE DAYS. ON 10/22/1997 THE PT HAD NO COMPLAINTS. THE PHYSICIAN REMOVED THE SUTURES; HE NOTED THAT THE IMPLANTS APPEARED TO BE IN CORRECT POSITION, THE INCISIONS APPEARED TO BE HEALING WELL, AND THERE WAS NO FACIAL SWELLING, BRUISING, INFLAMMATION OR DRAINAGE. ON 11/19/1997 THE PHYSICIAN NOTED THAT THE RIGHT NASOLABIAL ENTRANCE INCISION APPEARED LUMPY AND WAS DRAINING FLUID (EXACT NATURE AND DATE OF ONSET NOT RECORDED). HE INCISED AND CLEANED THE SITE AND LEFT IT OPEN TO DRAIN. ON APPROXIMATELY 11-21-1997 THE PT REPORTED A CONTINUATION OF MINIMAL DRAINAGE, SLIGHT LUMPINESS AND SOME DISCOMFORT AT THE AFFECTED SITE. THE PHYSICIAN DIRECTED THE PT TO CONTINUE ON KEFLEX. ON 12/3/1997 THE PHYSICIAN OBSERVED IMPROVED BUT CONTINUED OZZING INFLAMMATION AND LUMPINESS AND SOME DISCOMFORT AT THE AFFECTED SITE. THE PHYSICIAN DIRECTED THE PT TO CONTINUE ON KEFLEX. ON 12/3/1997 THE PHYSICIAN OBSERVED IMPROVED BUT CONTINUED OOZING, INFLAMMATION AND LUMPINESS AT THE AFFECTED SITE. HE NOTED THAT THE IMPLANT DID NOT APPEAR TO SETTLE DOWN AND SEAT ITSELF IN THE FOLD, AND THAT IT APPEARED TO HAVE SHRUNK. HE DID NOT NOTE WHETHER HE BELIEVED THE IMPLANT WAS EXTRUDED. HE INJECTED THE SITE WITH KENALOG AND DIRECTED THE PT TO CONTINUE ON KEFLEX. ON 12/16/1997 THE PHYSICIAN REMOVED THE RIGHT NASOLABIAL IMPLANT DUE TO CONTINUED DRAINAGE FROM THE SITE AND PRESCIBED ORAL AUGMENTIN. ON 12/23/1997, THE EXPLANT WAS RETURNED TO THE DISTRIBUTOR FOR ANALYSIS. AFTER THE ANALYSIS IS COMPLETE, A REPORT WILL BE FORWARDED TO THE MFR. DESCRIPTIONS OF ALL PT PROBLEM CODES: WOUND DRAINAGE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 SOFTFORM FACIAL IMPLANT Implant SOFTFORM FTL TISSUE TECHNOLOGIES, INC NA 97J191A

Patients

Seq Age Sex Outcome Treatment
1 40 YR Required Intervention COLLAGEN TEST IMPLANT (10/17/1997 TO 10/17/1997).